BioSpace News Archive

We challenge you to stop doing these things next week and see how your work productivity skyrockets. So practice avoiding these productivity killers at work.

We interviewed Patti Rossman, president of Globiox and co-founder of the Life Science Women’s Conference. Patti shared her insights from a diverse career with large organizations and in consulting.

Bespoke approach generates high affinity antibodies and selects lead candidates with the strongest chances of success in the clinic

Industry veterans including Craig Lipset will support the Castor’s vision to advance the future of clinical research

On Monday, the U.S. Supreme Court refused to overturn his seven-year conviction for securities fraud.

CRISPR Therapeutics and Vertex Pharmaceuticals announced positive interim data from the first two patients in the companies’ ongoing Phase I/II clinical trials of its CRISPR/Cas9 gene-editing therapy CTX001.

Myovant announced that its Phase III HERO trial relugolix met its primary endpoint and six key secondary endpoints in advanced prostate cancer.

Saurabh Kapure, Vice President, Business Development, USA for Jubilant Biosys, recently sat down with Bob Volkmann, PhD, Founder and Chief Scientific Officer, at BioPharmaWorks.

The reclassification of prescription drugs and the increasing trend for self-care are two factors which drive growth of the global over-the-counter drugs and dietary supplements market, according to a report by BCC Research, “Over-the-Counter Drugs and Dietary Supplements: Opportunities for Consumer Goods Distributors.”

If successful, the CEO told BioSpace in an exclusive interview that Acelarin will break the glass ceiling as the first FDA-approved treatment for biliary tract cancer.